Previous close | 1.8800 |
Open | 1.9200 |
Bid | 1.8800 x 0 |
Ask | 1.9000 x 0 |
Day's range | 1.8800 - 1.9200 |
52-week range | 0.8100 - 2.0800 |
Volume | |
Avg. volume | 28,081 |
Market cap | 29.511M |
Beta (5Y monthly) | 0.95 |
PE ratio (TTM) | 14.46 |
EPS (TTM) | 0.1300 |
Earnings date | 22 May 2024 - 27 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results for the three and twelve-month periods ended December 31, 2023. Biorem's complete fiscal 2023 year-end financial statements and MD&A have been filed on SEDAR (www.sedar.com).
BIOREM Inc. (TSXV: BRM) ("BIOREM" or "The Company") today announced its results for the three and nine-month periods ended September 30, 2023. BIOREM's complete second quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results for the three and six-month periods ended June 30, 2023. Biorem's complete second quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).